<- Go Home

iBio, Inc.

iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States.

Market Cap

$20.8M

Volume

965.8K

Cash and Equivalents

$5.3M

EBITDA

-$17.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$50.0K

Profit Margin

100.00%

52 Week High

$17.60

52 Week Low

$1.02

Dividend

N/A

Price / Book Value

0.83

Price / Earnings

-0.27

Price / Tangible Book Value

1.05

Enterprise Value

$33.4M

Enterprise Value / EBITDA

-2.00

Operating Income

-$18.2M

Return on Equity

-81.08%

Return on Assets

-24.05

Cash and Short Term Investments

$5.3M

Debt

$18.0M

Equity

$24.9M

Revenue

$50.0K

Unlevered FCF

-$16.7M

Sector

Biotechnology

Category

N/A

Company Stock Pitches